Multiple Myeloma in Italy: An Epidemiological Model by Treatment Line and Refractoriness Status

Our model revealed a rising prevalence of patients receiving first-line treatment owing to more effective treatments. The marked increase in the number of refractory patients in subsequent lines underscores the urgent need for innovative therapies to address treatment resistance.